EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Antiphospholipid Syndrome: A Comprehensive Clinical Review

Vasileios Patriarcheas iD, Georgios Tsamos, Dimitra Vasdeki iD, Elias Kotteas iD, Anastasios Kollias iD, Dimitris Nikas, Georgia Kaiafa, Evangelos Dimakakos iD

Journal of Clinical Medicine · 23.01.2025 · 14 (3) · 733

DOI: 10.3390/jcm14030733 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 23.01.2025. Verfasst von Vasileios Patriarcheas und 7 weiteren Autor:innen. Beteiligte Einrichtung: First Propaedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, AHEPA University Hospital, Stilponos Kyriakides 1 Str., 546…. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antiphospholipid syndrome (APS) is a rare systemic autoimmune disease characterized by persistent antiphospholipid antibodies (aPL) in combination with recurrent thrombosis in the veins and/or arteries, obstetric morbidity, and various non-thrombotic associated complications. APS can be primary, as an isolated condition, or secondary in the context of another autoimmune disease, especially systemic lupus erythematosus. This comprehensive clinical review aims to summarize the current understanding of APS pathogenesis, diagnostic approaches, and treatment strategies for this unique clinical entity.

Methods

A comprehensive review of the existing literature on APS was conducted, focusing on pathophysiological mechanisms, current diagnostic criteria, and therapeutic approaches.

Results

APS pathogenesis involves complex interactions between aPL, phospholipid-binding proteins, and the coagulation cascade. Apart from the cardinal features of thrombosis and APS-related obstetric morbidity, APS is associated with a wide spectrum of clinical manifestations. Diagnosis remains challenging due to overlapping symptoms with other conditions, and clinicians should maintain a high index of suspicion in order to set the diagnosis. The recently published 2023 ACR/EULAR criteria although not definitive for clinical decision-making, these criteria offer clinicians a valuable tool to aid in determining whether further investigation for APS is warranted. Continued refinement of these criteria through ongoing feedback and updates is anticipated. Treatment strategies center on anticoagulation, but individualized approaches are necessary.

Conclusions

Early diagnosis and multidisciplinary management of APS are critical to reducing morbidity and improving outcomes. Moreover, familiarization with the 2023 ACR/EULAR criteria is encouraged, recognizing that ongoing feedback and updates will contribute to their ongoing refinement and improvement. While VKAs remain the mainstay of treatment for most APS patients further research is needed to optimize treatment strategies and deepen our understanding of APS’s underlying disease mechanisms.

Schlagwörter

Stichwörter der Autor:innen

anti β2-GPIanticardiolipinantiphospholipid syndromeautoantibodiescatastrophic antiphospholipid syndromelupus anticoagulantthrombosis

Autor:innen und Institutionen

  • First Propaedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, AHEPA University Hospital, Stilponos Kyriakides 1 Str., 54636 Thessaloniki, Greece.
  • Second Propedeutic Department of Internal Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki, Konstantinoupoleos 49 Str., 54942 Thessaloniki, Greece.
  • Division of Endocrinology and Metabolism and Diabetes Centre, First Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital, Stilponos Kyriakides 1 Str., 54636 Th…
  • Oncology Unit, Third Department of Internal Medicine, Sotiria General Hospital for Chest Diseases, National and Kapodistrian University of Athens, 152 Mesogeion Ave., 11527 Athens, Greece.
  • Hypertension Center STRIDE-7, Third Department of Medicine, Sotiria Hospital, School of Medicine, National and Kapodistrian University of Athens, 152 Mesogeion Ave., 11527 Athens, Greece.
  • Anatomy and Histology Laboratory, Nursing School, University of Athens, Papadiamantopoulou 123 Str., 11527 Athens, Greece.

ORCID-Profile: Vasileios Patriarcheas, Dimitra Vasdeki, Elias Kotteas, Anastasios Kollias, Evangelos Dimakakos

Zitieren

APA

Patriarcheas, V., Tsamos, G., Vasdeki, D., Kotteas, E., Kollias, A., Nikas, D., Kaiafa, G., & Dimakakos, E. (2025). Antiphospholipid Syndrome: A Comprehensive Clinical Review. Journal of Clinical Medicine, 14(3), 733. https://doi.org/10.3390/jcm14030733

Vancouver

Patriarcheas V, Tsamos G, Vasdeki D, Kotteas E, Kollias A, Nikas D, et al. Antiphospholipid Syndrome: A Comprehensive Clinical Review. Journal of Clinical Medicine. 2025;14(3):733. doi:10.3390/jcm14030733

BibTeX
@article{Patriarcheas2025,
  author = {Patriarcheas, Vasileios and Tsamos, Georgios and Vasdeki, Dimitra and Kotteas, Elias and Kollias, Anastasios and Nikas, Dimitris and Kaiafa, Georgia and Dimakakos, Evangelos},
  title = {Antiphospholipid Syndrome: A Comprehensive Clinical Review},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {3},
  pages = {733},
  doi = {10.3390/jcm14030733}
}
Kostenlos starten →